Tomonori Nagamine
Kagoshima University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Tomonori Nagamine.
Bone | 1998
Toshiyuki Onishi; Yasuhiro Ishidou; Tomonori Nagamine; K Yone; Takeshi Imamura; Mitsuyasu Kato; T K Sampath; P ten Dijke; Takashi Sakou
Bone morphogenetic proteins (BMPs) and their receptors (BMPRs) are thought to play an important role in bone morphogenesis. The purpose of this study was to determine the locations of BMP-2/-4, osteogenic protein-1 (OP-1, also termed BMP-7), and BMP type II receptor (BMPR-II) during rat fracture healing by immunostaining, and thereby elucidate the possible roles of the BMPs and BMPR-II in intramembranous ossification and endochondral ossification. In the early stage of fracture repair, the expression of BMP-2/-4 and OP-1 was strongly induced in the thickened periosteum near the fracture ends, and coincided with an enhanced expression of BMPR-II. On day 7 after fracture, staining for BMP-2/-4 and OP-1 immunostaining was increased in various types of chondrocytes, and was strong in fibroblast-like spindle cells and proliferating chondrocytes in endochondral bone. On day 14 after fracture, staining with OP-1 antibody disappeared in proliferating and mature chondrocytes, while BMP-2/-4 staining continued in various types of chondrocytes until the late stage. In the newly formed trabecular bone, BMP-2/-4 and OP-1 were present at various levels. BMPR-II was actively expressed in both intramembranous ossification and endochondral ossification. Additionally, immunostaining for BMP-2/-4 and OP-1 was observed in multinucleated osteoclast-like cells on the newly formed trabecular bone, along with BMPR-II. In reference to our previous study of BMP type I receptors (BMPR-IA and BMPR-IB), BMPR-II was found to be co-localized with BMPR-IA and BMPR-IB. BMP-2/-4 and OP-1 antibodies exhibited distinct and overlapping immunostaining patterns during fracture repair. OP-1 may act predominantly in the initial phase of endochondral ossification, while BMP-2/-4 acts throughout this process. Thus, these findings suggested that BMPs acting through their BMP receptors may play major roles in modulating the sequential events leading to bone formation.
Journal of Bone and Mineral Research | 1999
Takashi Sakou; Toshiyuki Onishi; Takuya Yamamoto; Tomonori Nagamine; T. Kuber Sampath; Peter ten Dijke
Members of the transforming growth factor‐β (TGF‐β) family transduce signals from the cell membrane to the nucleus via specific type I and type II receptors and Smad proteins. Smad1 and Smad5 mediate intracellular signaling of bone morphogenetic protein (BMP), whereas Smad2 and Smad3 transduce TGF‐β signaling. Smad4 is a common mediator required for both pathways. Smad6 and Smad7 inhibit signaling by members of the TGF‐β superfamily. Here, we examined the expression of Smad1 to Smad7 proteins during endochondral ossification of epiphyseal plate of growing rats using immunohistochemical techniques. The expression of Smad proteins was correlated with the expression of TGF‐β1 and its receptors, and BMP‐2/4 and BMP receptors. The results show that TGF‐β1 and BMP‐2/4 were actively expressed in chondrocytes that are undergoing proliferation and maturation, which overlaps with expression of their corresponding type I and type II receptors. The Smads, however, exhibited a distinct expression pattern, respectively. For example, Smad1 and Smad5 were highly expressed in proliferating chondrocytes and in those chondrocytes that are undergoing maturation. The TGF‐β/activin‐restricted Smads were also expressed in a nearly complementary fashion; Smad2 was strongly expressed in proliferating chondrocytes, whereas Smad3 was strongly observed in maturing chondrocytes. Smad4 was broadly expressed in all zones of epiphyseal plate. Inhibitory Smads, Smad6 and Smad7, were strongly expressed in the zone of cartilage that contained mature chondrocytes. Our findings show a colocalization of the pathway‐restricted and inhibitory Smads with activating ligands or ligands whose action they antagonize and their receptors in various zones of epiphyseal growth plate, suggesting that TGF‐β superfamily Smad signaling pathways plays a morphogenic role during endochondral bone formation.
Journal of Neuropathology and Experimental Neurology | 1999
Shinji Nakahara; Kazunori Yone; Takashi Sakou; Shouichi Wada; Tomonori Nagamine; Takahito Niiyama; Hidenori Ichijo
The aims of this study were to clarify the mechanism of cell death by apoptosis in the spinal cord after traumatic injury, and to examine the role of the mitogen-activated protein kinase (MAPK) pathways in the transmission of apoptosis signals. The rat spinal cord, experimentally injured by extradural static weight-compression, was studied by hematoxylin and eosin staining, Nissl-staining, terminal deoxynucleotidyl transferase (TdT) mediated dUTP nick-end labeling (TUNEL) staining, and immunostaining using polyclonal antibodies against Apoptosis Signal-regulating Kinase 1 (ASK1), c-Jun N-terminal kinase (JNK), and p38 MAPK. TUNEL-positive cells were present at all stages studied until 7 days after injury, and percentage positivity for these cells was maximal at 3 days after injury. Electron microscopic analysis revealed the occurrence of apoptosis in both neuronal cells and glial cells. TUNEL-positive glial cells were stained by oligodendrocyte-specific maker. Expression of ASK1 was maximal at 24 h after injury in the gray matter and at 3 days after injury in the white matter. Following the expression of ASK1, activated forms of JNK and p38 were observed in apoptotic cells detected by the TUNEL method. Colocalization of ASK1 and activated JNK or activated p38 was observed in the same cell. These findings suggest the involvement of the stress-activated MAPK pathways including ASK1 in the transmission of apoptosis signals after spinal cord injury.
Bone | 1997
K. Hayashi; Yasuhiro Ishidou; Kouji Yonemori; Tomonori Nagamine; Nobuo Origuchi; Shingo Maeda; Takeshi Imamura; Mitsuyasu Kato; Hiroki Yoshida; T K Sampath; P ten Dijke; Takashi Sakou
To clarify the pathogenesis of ossification of the ligamentum flavum (OLF), we examined the expression and localization of bone morphogenetic proteins (BMPs) and their receptors (BMPRs) in the ligamentum flavum of the patients with OLF by immunohistochemical staining and compared them with staining patterns in control patients. The BMPRs appeared extensively in mature and immature chondrocytes around the calcified zone and in spindle-shaped cells and round cells in the remote part from ossified foci in examined tissue of OLF. The ligands for BMPRs, BMP-2/-4 and osteogenic protein-1 (OP-1)/BMP-7, colocalized in OLF patients. In the control cases, expression of BMPs and BMPRs was observed around the calcified zone at the insertion of the ligamentum flavum to the bone, and limited expression was found in the smaller range. Thus, the expression profile of BMPs and BMPRs in OLF patients was entirely different from the control patients, suggesting that BMPs may be involved in promoting endochondral ossification at ectopic ossification sites in OLF, and that ossification activity is continuous in these patients.
Spine | 2002
Ichiro Yamaura; Kazunori Yone; Shinji Nakahara; Tomonori Nagamine; Hisatoshi Baba; Kenzo Uchida; Setsuro Komiya
Study Design. A histologic and histochemical study was performed both in the autopsy of a human patient with cervical spinal cord compression caused by ossification of the posterior longitudinal ligament and in a tiptoe-walking Yoshimura mouse model of progressive cervical cord compression. Objectives. To clarify the mechanism of destructive pathologic changes in the spinal cord under chronic mechanical compression. Summary of Background Data. Under chronic compression, the spinal cord exhibits destructive changes considered to be causes of profound and irreversible motor paresis. Recently, some investigators have found that apoptosis in acute spinal cord injury induces both secondary degeneration at the site of injury and chronic demyelination of tracts away from the site of injury. However, the mechanism responsible for these destructive spinal cord changes under chronic compression remains unclear. Methods. The spinal cord was examined histologically, and an attempt was made to detect apoptotic cells using terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling in both the autopsy of a human patient and tiptoe-walking mice exhibiting spinal cord compression. Results. Apoptotic cells were observed in the chronically compressed spinal cord in both the autopsy of a human patient and model mice. In tiptoe-walking mice exhibiting spinal cord compression, descending degeneration in the anterior and lateral columns and ascending degeneration in the posterior column were observed. The distribution of oligodendrocytes with positive results from terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling was similar to that for degeneration of the long tracts. Conclusions. Spinal cord cell apoptosis may produce destructive changes in the spinal cord under chronic compression, with a resulting irreversible neurologic deficit.
Orthopaedics and Traumatology | 2007
Yoshiya Arishima; Hideyuki Kawabata; Tomonori Nagamine; Hironori Kakoi; Masahiro Yokouchi; Hiromi Hamada; Yusuke Fujimoto; Yasuhiro Ishido; Kosei Ijiri; Setsuro Komiya
(目的)キアリ骨盤骨切り術施行時と内固定材料抜釘時に股関節鏡を行い,鏡視所見と治療成績について検討した.(対象と方法)2001年以降のキアリ症例44例47股中,鏡視を行い得た10例10股(全例女性)を対象とした.手術時平均年齢は43歳で,抜釘術までの期間:平均1年1ケ月,病期分類は進行期3例,末期7例であった.評価はJOAスコアと種田分類を用いた.(結果と考察)JOAスコアは48点から74点に改善していた.種田分類では多くの症例で変化なかった.疼痛などの臨床所見はよく改善されていたが,関節鏡所見の変化は乏しく,臨床成績との関連性は明らかではなかった.またキアリ変法に関節内処置を併用することが,どれほど臨床成績の向上に貢献しているかも不明であるため,今後長期にわたる経過観察が必要であると思われる.
Journal of Neurosurgery | 1999
Shoichi Wada; Kazunori Yone; Yasuhiro Ishidou; Tomonori Nagamine; Shinji Nakahara; Takahito Niiyama; Takashi Sakou
Journal of Orthopaedic Research | 1998
Tomonori Nagamine; Takeshi Imamura; Yasuhird Ishidou; Mitsuyasu Kato; Fusayoshi Murata; Peter ten Dijke; Takashi Sakou
Anticancer Research | 1998
Yazaki Y; Syunji Matsunaga; Toshiyuki Onishi; Tomonori Nagamine; Nobuo Origuchi; Yamamoto T; Yasuhiro Ishidou; Takeshi Imamura; Takashi Sakou
Anticancer Research | 1998
Fukumura K; Syunji Matsunaga; Yamamoto T; Tomonori Nagamine; Yasuhiro Ishidou; Takashi Sakou